192 related articles for article (PubMed ID: 20596668)
1. The prostate transglutaminase, TGase-4, coordinates with the HGFL/MSP-RON system in stimulating the migration of prostate cancer cells.
Jiang WG; Ye L; Ablin RJ; Kynaston HG; Mason MD
Int J Oncol; 2010 Aug; 37(2):413-8. PubMed ID: 20596668
[TBL] [Abstract][Full Text] [Related]
2. The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells.
Feres KJ; Ischenko I; Hayman MJ
Oncogene; 2009 Jan; 28(2):279-88. PubMed ID: 18836480
[TBL] [Abstract][Full Text] [Related]
3. Comparative characterization of the HGF/Met and MSP/Ron systems in primary pancreatic adenocarcinoma.
Vanderwerff BR; Church KJ; Kawas LH; Harding JW
Cytokine; 2019 Nov; 123():154762. PubMed ID: 31254927
[TBL] [Abstract][Full Text] [Related]
4. Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.
Ablin RJ; Kynaston HG; Mason MD; Jiang WG
J Transl Med; 2011 Apr; 9():49. PubMed ID: 21524313
[TBL] [Abstract][Full Text] [Related]
5. Macrophage-stimulating protein and its receptor in non-small-cell lung tumors: induction of receptor tyrosine phosphorylation and cell migration.
Willett CG; Wang MH; Emanuel RL; Graham SA; Smith DI; Shridhar V; Sugarbaker DJ; Sunday ME
Am J Respir Cell Mol Biol; 1998 Apr; 18(4):489-96. PubMed ID: 9533936
[TBL] [Abstract][Full Text] [Related]
6. Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis.
Peace BE; Hughes MJ; Degen SJ; Waltz SE
Oncogene; 2001 Sep; 20(43):6142-51. PubMed ID: 11593422
[TBL] [Abstract][Full Text] [Related]
7. Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer.
Davies G; Ablin RJ; Mason MD; Jiang WG
J Exp Ther Oncol; 2007; 6(3):257-64. PubMed ID: 17552366
[TBL] [Abstract][Full Text] [Related]
8. MSP-induced RON activation upregulates uPAR expression and cell invasiveness via MAPK, AP-1 and NF-κB signals in gastric cancer cells.
Park JS; Park JH; Khoi PN; Joo YE; Jung YD
Carcinogenesis; 2011 Feb; 32(2):175-81. PubMed ID: 21081472
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of MSP-RON signaling pathway in cancer cells by a novel soluble form of RON comprising the entire sema sequence.
Ma Q; Zhang K; Yao HP; Zhou YQ; Padhye S; Wang MH
Int J Oncol; 2010 Jun; 36(6):1551-61. PubMed ID: 20428780
[TBL] [Abstract][Full Text] [Related]
10. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family.
Iwama A; Yamaguchi N; Suda T
EMBO J; 1996 Nov; 15(21):5866-75. PubMed ID: 8918464
[TBL] [Abstract][Full Text] [Related]
11. Identification of the ron gene product as the receptor for the human macrophage stimulating protein.
Wang MH; Ronsin C; Gesnel MC; Coupey L; Skeel A; Leonard EJ; Breathnach R
Science; 1994 Oct; 266(5182):117-9. PubMed ID: 7939629
[TBL] [Abstract][Full Text] [Related]
12. Ribosomal protein S6 kinase (RSK)-2 as a central effector molecule in RON receptor tyrosine kinase mediated epithelial to mesenchymal transition induced by macrophage-stimulating protein.
Ma Q; Guin S; Padhye SS; Zhou YQ; Zhang RW; Wang MH
Mol Cancer; 2011 May; 10():66. PubMed ID: 21619683
[TBL] [Abstract][Full Text] [Related]
13. Prostate transglutaminase (TGase-4, TGaseP) enhances the adhesion of prostate cancer cells to extracellular matrix, the potential role of TGase-core domain.
Jiang WG; Ye L; Sanders AJ; Ruge F; Kynaston HG; Ablin RJ; Mason MD
J Transl Med; 2013 Oct; 11():269. PubMed ID: 24161123
[TBL] [Abstract][Full Text] [Related]
14. Prostate Transglutaminase (TGase-4) Induces Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells.
Ablin RJ; Owen S; Jiang WG
Anticancer Res; 2017 Feb; 37(2):481-487. PubMed ID: 28179293
[TBL] [Abstract][Full Text] [Related]
15. The prostate transglutaminase (TGase-4, TGaseP) regulates the interaction of prostate cancer and vascular endothelial cells, a potential role for the ROCK pathway.
Jiang WG; Ablin RJ; Kynaston HG; Mason MD
Microvasc Res; 2009 Mar; 77(2):150-7. PubMed ID: 18983858
[TBL] [Abstract][Full Text] [Related]
16. Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells.
Tate A; Isotani S; Bradley MJ; Sikes RA; Davis R; Chung LW; Edlund M
BMC Cancer; 2006 Jul; 6():197. PubMed ID: 16869958
[TBL] [Abstract][Full Text] [Related]
17. Role of macrophage-stimulating protein and its receptor, RON tyrosine kinase, in ciliary motility.
Sakamoto O; Iwama A; Amitani R; Takehara T; Yamaguchi N; Yamamoto T; Masuyama K; Yamanaka T; Ando M; Suda T
J Clin Invest; 1997 Feb; 99(4):701-9. PubMed ID: 9045873
[TBL] [Abstract][Full Text] [Related]
18. Ron receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell lines.
McClaine RJ; Marshall AM; Wagh PK; Waltz SE
Neoplasia; 2010 Aug; 12(8):650-8. PubMed ID: 20689759
[TBL] [Abstract][Full Text] [Related]
19. Plasma macrophage-stimulating protein and hepatocyte growth factor levels are associated with prostate cancer progression.
Sugie S; Mukai S; Yamasaki K; Kamibeppu T; Tsukino H; Kamoto T
Hum Cell; 2016 Jan; 29(1):22-9. PubMed ID: 26250899
[TBL] [Abstract][Full Text] [Related]
20. Met-related receptor tyrosine kinase Ron in tumor growth and metastasis.
Wagh PK; Peace BE; Waltz SE
Adv Cancer Res; 2008; 100():1-33. PubMed ID: 18620091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]